NewCan Biotech Limited

NewCan Biotech Limited was established in 2021 and is primarily engaged in the research, development, production, and sales of sugars, nucleosides, nucleotides, phosphorylated monomers, as well as next-generation antiviral and antitumor drug intermediates. Our products are mainly used in new drug development, biocatalysis, PCR amplification, gene sequencing, diagnostic reagent production, and life science research. We have comprehensive laboratory, analysis, and production facilities equipped with a professional research and development team, enabling us to scale from small-scale trials and pilot studies to industrial production. As a leading company in the field, we are committed to providing high-quality raw materials and products to meet the needs of the pharmaceutical, biotechnology, and life science industries. Our products are characterized by their high purity, efficiency, and customizability, making them suitable for a wide range of applications and professional sectors. We have established a strong presence in the industry by continuously pursuing excellence and innovation. Our research and development team is experienced, passionate, and creative, constantly exploring cutting-edge technologies to ensure that our products remain at the forefront of the industry. We adhere to strict quality management systems to ensure that all our products meet international standards and customer requirements. In addition to our dedication to product quality, we prioritize environmental protection and sustainable development. We are committed to promoting green production practices and recycling to minimize our environmental impact. Our goal is to collaborate with global partners to explore new markets and achieve mutual success. Looking ahead, we will continue to uphold an innovative spirit, enhance our technological capabilities, and provide customers with high-quality products and services. We aim to become leaders and innovators in the industry by delivering exceptional value and contributing to advancements in pharmaceuticals, biotechnology, and life sciences.

• Acyclovir